As US medical device maker Medtronic looks to gain a stronger footing against the market’s top competitor Johnson & Johnson, reports say Medtronic has offered concessions to EU authorities to secure approval for its buyout plans.
Medtronic is seeking to acquire Irish rival Covidien for $43 billion. According to reports, that takeover would place Medtronic at a nearly even level with Johnson & Johnson and lessen its tax burden.
The European Commission said this week that Medtronic has submitted concessions for the deal, but declined to say what those concessions are. The watchdog said it will rule on the merger by November 28.
Earlier reports said Covidien was willing to sell certain assets to close the deal.
Medtronic is looking to increase its competitive edge and has denied any claims that the merger is an inversion deal aimed at lowering its tax rates, though the merger would accomplish just that.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI